Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease - Project One: A Phase IIB Clinical Trial of the Safety and Efficacy of a NOX1/4 Inhibitor in IPF
Grant
Overview
Affiliation
Overview
Date/time Interval
August 1, 2018 - July 31, 2023
Awarded By
National Heart, Lung, and Blood Institute/NIH/DHHS
Total Award Amount
1450170.00
Direct Costs
1097502.00
Sponsor Award Id
P01HL114470
Affiliation
Contributor
Gary Cutter
Investigator
Joao De Andrade
Investigator
Steven Duncan
Principal Investigator
Tracy Luckhardt
Investigator